Cost analysis of use of tranexamic Acid to prevent major bleeding complications in hip and knee arthroplasty surgery

American journal of orthopedics (Belle Mead, N.J.)

Volumn 43, Issue 10, 2014, Pages E217-E220

  Slover, James ^a   Bosco, Joseph ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; COST; DECISION SUPPORT SYSTEM; ECONOMICS; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; POSTOPERATIVE HEMORRHAGE; PROBABILITY; REOPERATION;

ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; MARKOV CHAINS; POSTOPERATIVE HEMORRHAGE; REOPERATION; TRANEXAMIC ACID;

EID: 84932114255     PISSN: None     EISSN: 19343418     Source Type: Journal    
DOI: None     Document Type: Article

References (0)